Adenosine A2A receptor antagonists revert sensory-motor and motor impairment in animal models of Parkinson

1
(No Transcript)
2
(No Transcript)
3
(No Transcript)
4
(No Transcript)
5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
(No Transcript)
11
(No Transcript)
12

• Adenosine A2A receptor antagonists revert
  sensory-motor and motor impairment in animal
  models of Parkinsons disease

13
(No Transcript)
14
(No Transcript)
15
(No Transcript)
16
(No Transcript)
17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
(No Transcript)
28
(No Transcript)
29
(No Transcript)
30
(No Transcript)
31
(No Transcript)
32
(No Transcript)
33
(No Transcript)
34
(No Transcript)
35
(No Transcript)
36
(No Transcript)
37
(No Transcript)
38
(No Transcript)
39
(No Transcript)
40
(No Transcript)
41
(No Transcript)
42
(No Transcript)
43
(No Transcript)
44
(No Transcript)
45
(No Transcript)
46
(No Transcript)
47
ACKNOWLEDGMENTS
Prof. Micaela Morelli Dr. Annalisa Pinna Dr.
Sandro Fenu Dept. of Toxicology, University of
Cagliari, Italy Dr. Silvia Pontis NIDA-NIH
Baltimore, USA Prof. Pier G. Baraldi Dr. Mojgan
A. Tabrizi Dept. of Pharmaceutical Sciences,
University of Ferrara, Italy Dr. Franco
Borsini Sigma-Tau Industries, Pomezia, Italy